Gräbner R
Biochem Pharmacol. 1987 Apr 1;36(7):1063-7. doi: 10.1016/0006-2952(87)90415-1.
On chronic treatment certain amphiphilic drugs induce a generalized phospholipidosis. This drug side effect has been related to an inhibition of the lysosomal phospholipases due to the interaction of the drugs with phospholipids (PL). In the present experiments, the influence of the amphiphilic drugs ambroxol, imipramine, chloroquine and chlorphentermine on the hydrolysis of dipalmitoyl-phosphatidylcholine (DPPC) unilamellar liposomes by bee venom phospholipase A2 (PLase A2) was studied. Special emphasis was laid on the initial phase and temperature dependence. The activity of PLase A2 was measured continuously with a spectrophotometric assay using cresol red as indicator. In most cases a lag-phase of different duration was observed before the enzyme exhibited its full activity. The duration of the lag-phase and the rate of hydrolysis in the second phase are inversely related. The temperature dependence of the hydrolysis reveals a maximum of activity near the phase transition of the bilayer and a gradually decreasing activity at lower and higher temperatures, respectively. The analysis of the influence of amphiphilic drugs reveals three types of interaction. Imipramine and ambroxol shift the temperature activity profile towards lower temperatures without a substantial influence on the shape of the profile and on the maximal rate of hydrolysis. Chloroquine inhibits the enzyme activity without any temperature dependence. Chlorphentermine, the classical lipidosis inducing drug, exhibits a third type of interaction which seems to be a combination of the two former types.
在长期治疗中,某些两亲性药物会引发全身性磷脂沉积症。这种药物副作用与药物与磷脂(PL)相互作用导致溶酶体磷脂酶受抑制有关。在本实验中,研究了两亲性药物氨溴索、丙咪嗪、氯喹和氯苯丁胺对蜂毒磷脂酶A2(PLase A2)水解二棕榈酰磷脂酰胆碱(DPPC)单层脂质体的影响。特别强调了初始阶段和温度依赖性。使用甲酚红作为指示剂,通过分光光度法连续测量PLase A2的活性。在大多数情况下,在酶展现出其全部活性之前观察到不同持续时间的延迟期。延迟期的持续时间与第二阶段的水解速率呈负相关。水解的温度依赖性显示在双层的相变附近活性最高,在较低和较高温度下活性分别逐渐降低。对两亲性药物影响的分析揭示了三种相互作用类型。丙咪嗪和氨溴索将温度活性曲线向较低温度移动,而对曲线形状和最大水解速率没有实质性影响。氯喹抑制酶活性且无任何温度依赖性。氯苯丁胺,经典的致脂质沉积症药物,表现出第三种相互作用类型,似乎是前两种类型的组合。